Forte T M, McCall M R
Life Sciences Division, Lawrence Berkeley Laboratory, Berkeley, California.
Curr Opin Lipidol. 1994 Oct;5(5):354-64. doi: 10.1097/00041433-199410000-00007.
The inverse relationship between HDL and apolipoprotein A-I concentrations and the risk for premature atherosclerosis is well established, but the mechanism whereby apolipoprotein A-I offers protection is still somewhat elusive. Recent studies suggest that a specific subpopulation within the lipoprotein (AI) subclass may be more effective than others in promoting cholesterol efflux from cells. In addition, it appears that the lipid-free form of apolipoprotein A-I may have an important role in the antiatherosclerotic process. Unique new functions of apolipoprotein A-I-containing particles in modulating cytokines and lipid hydroperoxide transport, together with their role in antiatherogenesis, are also discussed. Current research with transgenic mice, however, indicates that apolipoprotein A-II must be taken into consideration in understanding the development of atherosclerosis, because it appears to be a potent antagonist for the protective properties of apolipoprotein A-I.
高密度脂蛋白(HDL)与载脂蛋白A-I浓度之间的负相关关系以及早发性动脉粥样硬化的风险已得到充分证实,但载脂蛋白A-I提供保护的机制仍有些难以捉摸。最近的研究表明,脂蛋白(AI)亚类中的一个特定亚群在促进细胞内胆固醇流出方面可能比其他亚群更有效。此外,载脂蛋白A-I的无脂形式似乎在抗动脉粥样硬化过程中起重要作用。还讨论了含载脂蛋白A-I颗粒在调节细胞因子和脂质氢过氧化物转运方面的独特新功能,以及它们在抗动脉粥样硬化发生中的作用。然而,目前对转基因小鼠的研究表明,在理解动脉粥样硬化的发展过程中必须考虑载脂蛋白A-II,因为它似乎是载脂蛋白A-I保护特性的有力拮抗剂。